May 13, 2014

Eastern Virginia Medical School Study Indicates Major Glycemic Improvement in Subcutaneous Basal Bolus Insulin Delivery Using eGlycemic Management System

Poster presented during AACE shows improved outcomes using Glytec’s subcutaneous insulin dosing solution versus traditional basal bolus insulin therapy.

Glytec, a clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control, is pleased to share the results of a late-breaking poster that was presented at the American Association of Clinical Endocrinologists (AACE) 23rd Annual Scientific and Clinical Congress. The poster is based on results experienced by Sentara Healthcare during the first 30 days after using Glytec’s Glucommander™ SubQ to manage subcutaneous Basal Bolus Insulin (BBI) therapy. The poster was presented by Joseph Aloi, MD, clinical director of the Strelitz Diabetes Center at Eastern Virginia Medical School, during the Congress’s general poster session.

May 7, 2014

Sentara Healthcare Ushers in a New Standard of Care in Glucose Management

Leading hospital system achieves dramatic reductions in occurrences of hyperglycemia and hypoglycemia, reduces length of stay.

Sentara Healthcare, a 12-hospital, not-for-profit health system serving Virginia and northeastern North Carolina, widely recognized for clinical excellence and IT innovation, today announced that they have achieved dramatic improvements in inpatient glucose management through the utilization of the eGlycemic Management System® (eGMS®), developed by Glytec.

May 14, 2013

Mountain States Health Alliance Achieves Dramatic Improvements in Glycemic Control with the Comprehensive Insulin-dosing Software Platform from Glytec

Thirteen-hospital system serving 29 counties in Tennessee, Virginia, Kentucky, and North Carolina applauds the solution for its integration, usability, and impact on patient care.

Glytec, a clinical information technology company dedicated to glycemic management solutions for hospitals and patients, today announced that Mountain States Health Alliance (MSHA) has experienced unprecedented clinical results in just the first 60 days of use of the inpatient glycemic control platform, Glucommander™.

June 28, 2010

Computerized Algorithm Can Enable Tight Glycemic Control

The Glucommander computerized intravenous insulin controller (CIIC) for insulin dosing enables providers to avoid hypoglycemia by accurately controlling patients’ blood glucose to desired target levels.

What if your facility could safely and effectively achieve tight glycemic control among patients in the intensive care unit (ICU) with little danger of severe hypoglycemia? According to study results presented at the American Diabetes Association 70th Scientific Sessions, this outcome is possible through the use of Glucommander, a computerized algorithm that accurately manages intravenous insulin.